Why a COVID-19 vaccine trial would take a break

0
40


In this week’s episode PODCAST-19, we discuss the news that AstraZeneca’s COVID-19 vaccine trial has been suspended due to a serious side effect for a participant, and how the temporary shutdown from a trial can sometimes mean that the process is working as expected.

Par Anna Rothschild and Sinduja Srinivasan

LEAVE A REPLY

Please enter your comment!
Please enter your name here